TrialEmerging microbes & infections2024

HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study.

Tao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.